Evaluation of maternal serum SERPINC1, E-selectin, P-selectin, RBP4 and PP13 levels in pregnancies complicated with preeclampsia

References

• American college of obstetricians and gynecologists (ACOG) practice bulletin no. 222: gestational hypertension and preeclampsia. Obstet Gynecol. 2020;135(6):e237–e260.
   PubMed Web of Science ®Google Scholar
• O’Brien TE, Ray JG, Chan WS. Maternal body mass index and the risk of preeclampsia: a systematic overview. Epidemiology. 2003;14(3):368–374.
   PubMed Web of Science ®Google Scholar
• Stepan H, Faber R, Froster UG, et al. Preeclampsia as a three stage problem: a work shop report. Placenta. 2004;25(6):585–587.
   PubMedGoogle Scholar
• Brosens JJ, Pijnenborg R, Brosens IA. The myometrial junctional zone spiral arteries in normal and abnormal pregnancies: a review of the literature. Am J Obstet Gynecol. 2002;187(5):1416–1423.
   PubMed Web of Science ®Google Scholar
• Crocker IP, Cooper S, Ong SC, et al. Differences in apoptotic susceptibility of cytotrophoblasts and syncytiotrophoblasts in normal pregnancy to those complicated with preeclampsia and intrauterine growth restriction. Am J Pathol. 2003;162:637–643.
   PubMed Web of Science ®Google Scholar
• Brosens IA. Morphological changes in the utero-placental bed in pregnancy hypertension. Clin Obstet Gynaecol. 1977;4(3):573–593.
   PubMed Web of Science ®Google Scholar
• Yang Q, Graham TE, Mody N, et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature. 2005;436(7049):356–362.
   PubMed Web of Science ®Google Scholar
• Sun Q, Kiernan UA, Shi L, et al. Plasma retinol-binding protein 4 (RBP4) levels and risk of coronary heart disease: a prospective analysis among women in the nurses’ health study. Circulation. 2013;127(19):1938–1947.
   PubMed Web of Science ®Google Scholar
• Mol B, Roberts CT, Thangaratinam S, et al. Pre-eclampsia. Lancet. 2016;387(10022):999–1011.
   PubMed Web of Science ®Google Scholar
• )Scioscia M, Gumaa K, Rademacher TW. Rademacher TW the link between insulin resistance and preeclampsia: new perspectives. J Reprod Immunol. 2009;82(2):100–105.
   PubMed Web of Science ®Google Scholar
• Feng Y, Ma X, Deng L. Role of selectins and their ligands in human implantation stage. Glycobiology. 2017;27(5):385–391.
   PubMed Web of Science ®Google Scholar
• Holthe MR, Staff AC, Berge LN, et al. Different levels of platelet activation in preeclamptic, normotensive pregnant, and nonpregnant women. Am J Obstetr Gynecol. 2004;190(4):1128–1134.
   PubMed Web of Science ®Google Scholar
• Gadde R, Cd D, Sheela SR. Placental protein 13: an important biological protein in preeclampsia. J Circ Biomark. 2018;7:1849454418786159.
   Google Scholar
• Huntington JA. Shape-shifting serpins–advantages of a mobile mechanism. Trends Biochem Sci. 2006;31(8):427–435.
   PubMed Web of Science ®Google Scholar
• Hathcock J. Vascular biology-the role of tissue factor. Semin Hematol. 2004;41(1 Suppl 1):30–34.
   PubMed Web of Science ®Google Scholar
• Gatto M, Iaccarino L, Ghirardello A, et al. Serpins, immunity and autoimmunity: old molecules, new functions. Clin Rev Allergy Immunol. 2013;45(2):267–280.
   PubMed Web of Science ®Google Scholar
• Weenink GH, Kahlé LH, Lamping RJ, et al. Antithrombin III in oral contraceptive users and during normotensive pregnancy. Acta Obstet Gynecol Scand. 1984;63(1):57–61.
   PubMed Web of Science ®Google Scholar
• ACOG. Practice Bulletin No 202: gestational hypertension and preeclampsia. Obstet Gynecol. 2019;133(1):1.
   PubMed Web of Science ®Google Scholar
• Ölmez F, Oğlak SC, Gedik Özköse Z. Increased maternal serum aquaporin-9 expression in pregnancies complicated with early-onset preeclampsia. J Obstet Gynaecol Res. 2022;48(3):647–653.
   PubMed Web of Science ®Google Scholar
• Behram M, Oğlak SC, Doğan Y. Evaluation of BRD4 levels in patients with early-onset preeclampsia. J Gynecol Obstet Hum Reprod. 2021;50(2):101963.
   PubMed Web of Science ®Google Scholar
• Gu Y, Lewis DF, Wang Y. Placental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnancies. J Clin Endocrinol Metab. 2008;93(1):260–266.
   PubMed Web of Science ®Google Scholar
• Kovac M, Mitic G, Mikovic Z, et al. Thrombophilia in women with pregnancy-associated complications: fetal loss and pregnancy-related venous thromboembolism. Gynecol Obstet Investig. 2010;69(4):233–238.
   PubMed Web of Science ®Google Scholar
• Mello G, Parretti E, Marozio L, et al. Thrombophilia is significantly associated with severe preeclampsia: results of a large-scale, case-controlled study. Hypertension (Dallas, Tex.: 1979). 2005;46(6):1270–1274.
   PubMed Web of Science ®Google Scholar
• Dehkordi MA, Soleimani A, Haji-Gholami A, et al. Association of deficiency of coagulation factors (prs, prc, ATIII) and FVL positivity with preeclampsia and/or eclampsia in pregnant women. Int J Hematol Oncol Stem Cell Res. 2014;8(4):5–11.
   PubMedGoogle Scholar
• Zhou C, Song C, Huang X, et al. Early prediction model of gestational hypertension by multi-biomarkers before 20 weeks gestation. Diabetes Metab Syndr Obes. 2021;14:2441–2451.
   PubMed Web of Science ®Google Scholar
• Tomczykowska M, Bielak J, Bodys A. Evaluation of platelet activation, plasma antithrombin III and alpha2-antiplasmin activities in hypertensive patients. Ann Univ Mariae Curie Sklodowska Med. 2003;58(1):15–20.
   PubMedGoogle Scholar
• Shinyama H, Yamanaga K, Akira T, et al. Antithrombin III prevents blood pressure elevation and proteinuria induced by high salt intake in pregnant stroke-prone spontaneously hypertensive rats. Biol Pharm Bull. 1996;19(6):819–823.
   PubMed Web of Science ®Google Scholar
• Weenink GH, Treffers PE, Vijn P, et al. Antithrombin III levels in preeclampsia correlate with maternal and fetal morbidity. Am J Obstet Gynecol. 1984;148(8):1092–1097.
   PubMed Web of Science ®Google Scholar
• Daskalakis G, Papapanagiotou A. Serum markers for the prediction of preeclampsia. J Neurol Neurophysiol. 2015;6:264.
   Google Scholar
• Luo Q, Han X. Second-trimester maternal serum markers in the prediction of preeclampsia. J Perinat Med. 2017;45(7):809–816.
   PubMed Web of Science ®Google Scholar
• Sammar M, Drobnjak T, Mandala M, et al. Galectin 13 (PP13) facilitates remodeling and structural stabilization of maternal vessels during pregnancy. Int J Mol Sci. 2019;20(13):3192.
   PubMed Web of Science ®Google Scholar
• Sammar M, Dragovic R, Meiri H, et al. Reduced placental protein 13 (PP13) in placental derived syncytiotrophoblast extracellular vesicles in preeclampsia – a novel tool to study the impaired cargo transmission of the placenta to the maternal organs. Placenta. 2018;66:17–25.
   PubMed Web of Science ®Google Scholar
• Nasser NB, Al-Habib RM, Risala MJ. Correlation between serum & urinary placental protein (Pp13) in pre-eclamptic women at their third trimester. Indian J. Forensic Med. Toxicol. 2020;14:1814–1818.
   Google Scholar
• Asiltas B, Surmen-Gur E, Uncu G. Prediction of first-trimester preeclampsia: relevance of the oxidative stress marker MDA in a combination model with PP-13, PAPP-A and beta-HCG. Pathophysiology. 2018;25(2):131–135.
   PubMedGoogle Scholar
• Wu Y, Liu Y, Ding Y. Predictive performance of placental protein 13 for screening preeclampsia in the first trimester: a systematic review and meta-analysis. Front Med. 2021;8:756383.
   Web of Science ®Google Scholar
• )Mazakitovi S, Romero R, Vaisbuch E, et al. Maternal serum adiponectin multimers in preeclampsia. J Perinatal Med. 2009;37:349.
   PubMed Web of Science ®Google Scholar
• Seol HJ, Kim JW, Kim HJ. Retinol-binding protein-4 is decreased in patients with preeclampsia in comparison with normal pregnant women. J Perinat Med. 2011;39(3):287–289.
   PubMed Web of Science ®Google Scholar
• Shangguan X, Liu F, Wang H, et al. Alterations in serum adipocyte fatty acid binding protein and retinol binding protein-4 in normal pregnancy and preeclampsia. Clin Chim Acta. 2009;407(1-2):58–61.
   PubMed Web of Science ®Google Scholar
• Masuyama H, Inoue S, Hiramatsu Y. Retinol-binding protein 4 and insulin resistance in preeclampsia. Endocr J. 2011;58(1):47–53.
   PubMed Web of Science ®Google Scholar
• )Stepan H, Ebert T, Schrey S, et al. Preliminary report: serum levels of retinol-binding protein 4 in preeclampsia. Metab.: clin Exp. 2009;58:275.
   PubMed Web of Science ®Google Scholar
• Acar A, Altinbaş A, Oztürk M, et al. Selectins in normal pregnancy, preeclampsia and missed abortus. Haematologia (Budap). 2001;31(1):33–38.
   PubMedGoogle Scholar
• Gaugler-Senden IP, Tamsma JT, van der Bent C, et al. Angiogenic factors in women ten years after severe very early onset preeclampsia. PLOS One. 2012;7(8):e43637.
   PubMed Web of Science ®Google Scholar
• Docheva N, Romero R, Chaemsaithong P, et al. The profiles of soluble adhesion molecules in the “great obstetrical syndromes. J Matern Fetal Neonatal Med. 2019;32(13):2113–2136.
   PubMed Web of Science ®Google Scholar
• Mistry HD, Ogalde MVH, Broughton Pipkin F, et al. Maternal, fetal, and placental selectins in women with preeclampsia; association with the renin-angiotensin-system. Front Med. 2020;7:270.
   Web of Science ®Google Scholar
• Krieglstein CF, Granger DN. Adhesion molecules and their role in vascular disease. Am J Hypertens. 2001;14(6 Pt 2):44S–54S.
   PubMed Web of Science ®Google Scholar
• Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308(5728):1592–1594.
   PubMed Web of Science ®Google Scholar
• Hassan HE, Azzam H, Othman M, et al. Soluble E-selectin, platelet count and mean platelet volume as biomarkers for preeclampsia. Pregnancy Hypertens. 2019;17:1–4.
   PubMed Web of Science ®Google Scholar